SEARCH

SEARCH BY CITATION

Figure S1. The flow of study selection regarding epidemiology, pathogenesis, diagnosis and treatment of NAFLD/NASH.

Table S1. Liver fat score and liver fat equation for the prediction and quantitation of hepatic steatosis ((82) of main text).

Table S2. Biomarker panels for non-invasive assessment of the severity of liver disease in NAFLD.

Table S3. Therapeutic trials of weight loss and insulin sensitizers in NAFLD.

Table S4. Optimal nutrient composition in-patients with NAFLD.

Please note: Wiley-Blackwell are not responsible for the content or functionality of any supporting materials supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for the article.

FilenameFormatSizeDescription
OBR_657_sm_Fig_S1.doc36KSupporting info item
OBR_657_sm_Tabs_S1-S4.doc370KSupporting info item

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.